Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120K Hold
5,000
0.08% 72
2026
Q1
$140K Hold
5,000
0.1% 52
2025
Q4
$124K Hold
5,000
0.09% 56
2025
Q3
$127K Hold
5,000
0.1% 52
2025
Q2
$121K Buy
+5,000
New +$117K 0.1% 54
2025
Q1
Sell
-534
Closed -$14.2K 161
2024
Q4
$14.2K Buy
+534
New +$14.5K 0.01% 119
2024
Q2
Sell
-6,706
Closed -$178K 154
2024
Q1
$178K Sell
6,706
-710
-10% -$19.7K 0.16% 32
2023
Q4
$226K Sell
7,416
-420
-5% -$12.7K 0.22% 30
2023
Q3
$260K Sell
7,836
-160
-2% -$5.66K 0.27% 30
2023
Q2
$293K Sell
7,996
-270
-3% -$10.5K 0.28% 33
2023
Q1
$335K Sell
8,266
-960
-10% -$41.5K 0.38% 31
2022
Q4
$462K Hold
9,226
0.49% 25
2022
Q3
$404K Sell
9,226
-3,570
-28% -$173K 0.48% 28
2022
Q2
$671K Hold
12,796
0.75% 23
2022
Q1
$662K Sell
12,796
-1,158
-8% -$60.1K 0.68% 22
2021
Q4
$824K Hold
13,954
0.82% 23
2021
Q3
$600K Buy
13,954
+158
+1% +$7K 0.65% 28
2021
Q2
$540K Buy
13,796
+2,220
+19% +$86.3K 0.61% 30
2021
Q1
$419K Sell
11,576
-1,180
-9% -$41.9K 0.52% 33
2020
Q4
$458K Buy
+12,756
New +$468K 0.84% 15

Other funds holding PFE

Hoese & Co's PFE Position: Q2 2026 in Review

Hoese & Co held its Pfizer (PFE) position steady in Q2 2026 at 5,000 shares worth $120K. The position accounts for 0.08% of the portfolio, ranked #72.

Hoese & Co first reported a position in PFE in Q4 2020 and has held it in 20 quarters since. The position peaked at $824K in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hoese & Co held 5,000 shares of Pfizer worth $120K as of Q2 2026.
  • Hoese & Co left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.08% of Hoese & Co's portfolio in Q2 2026, its #72 holding.
  • Hoese & Co first reported a position in Pfizer in Q4 2020 and has held it in 20 quarters since.
  • Hoese & Co's Pfizer position peaked at $824K in Q4 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hoese & Co's 13F filing for Q2 2026, filed 14 Jul 2026.